Nintedanib-induced glomerular microangiopathy: a case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nintedanib-induced glomerular microangiopathy: a case report

Published:2020-04-11 Issue:4 Volume:9 Page:295-300
ISSN:2192-4449
Container-title:CEN Case Reports
language:en
Short-container-title:CEN Case Rep

Author:

Hasegawa Masataka,Uehara Atsuko,Suzuki Tomo,Sekine Reio,Yazawa Masahiko,Ichikawa Daisuke,Koike Junki,Shibagaki Yugo

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://link.springer.com/content/pdf/10.1007/s13730-020-00474-w.pdf

Reference15 articles.

1. Richeldi L, Costabel U, Selman M, Kim DS, Hansell DM, Nicholson AG, Brown KK, Flaherty KR, Noble PW, Raghu G, Brun M, Gupta A, Juhel N, Klüglich M, du Bois RM. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med. 2011;365:1079–87.

2. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown K, Ulrich C, Cottn V, Klaherty K, Hansell D, Inouei Y, Kim DS, for the INPULSIS Trial Investigators, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2071–82.

3. Reck M, Kaiser R, Mellemgaard A, Douillard JY, Orlov S, Krzakowski M, von Pawel J, Gottfried M, Bondarenko I, Liao M, Gann CN, Barrueco J, Gaschler-Markefski B, LUME-Lung Study Group. Novello S Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial. Lancet Oncol. 2014;15:143–55.

4. Estrada CC, Maldonado A, Mallipattu SK. Therapeutic inhibition of VEGF signaling and associated nephrotoxicities. J Am Soc Nephrol. 2019;30:187–200.

5. Ismail I, Nigam S, Parnham A, Srinivasa V. Anti-glomerular basement membrane glomerulonephritis following nintedanib for idiopathic pulmonary fibrosis: a case report. J Med Case Rep. 2017;11:214.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibrosis in Chronic Kidney Disease: Pathophysiology and Therapeutic Targets;Journal of Clinical Medicine;2024-03-25

2. Validation of IgA nephropathy diagnosis in the Swedish Renal Registry;BMC Nephrology;2024-03-04

3. Innate Immunity and CKD: Is There a Significant Association?;Cells;2023-11-27

4. Antifibrotic Agents for the Management of CKD: A Review;American Journal of Kidney Diseases;2022-08

5. Nintedanib-Induced Renal Thrombotic Microangiopathy;Case Reports in Nephrology and Dialysis;2021-07-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3